Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
qidan xiaoke granules + standard medical therapy
- Development stage
- Unknown
- Lead developer
- Liu Qiang
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Qidan Xiaoke Granules is a Traditional Chinese Medicine (TCM) herbal compound being investigated as an adjunctive therapy to standard medical therapy (SMT) for the management of patients following coronary revascularization procedures, such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). The combination therapy involves the administration of the herbal granules alongside guideline-directed medical treatments, which typically include dual antiplatelet therapy, statins, beta-blockers, and ACE inhibitors or ARBs. The granules are intended to reduce the incidence of major adverse cardiovascular events (MACE) and improve postoperative rehabilitation. The name "Xiaoke" traditionally refers to diabetes-related symptoms in TCM, suggesting the formula may target metabolic aspects of cardiovascular disease in patients with coronary heart disease.
- Other names
- Qidan Xiaoke GranulesQidan Xiaohe GranulesChinese Herbal Compound Qidan Xiaoke Granules
Beyond the preview
Go deeper on qidan xiaoke granules + standard medical therapy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on qidan xiaoke granules + standard medical therapy.